Milestone Scientific, Inc. Common Stock (MLSS) is a publicly traded Healthcare sector company. As of May 21, 2026, MLSS trades at $0.39 with a market cap of $28.62M and a P/E ratio of -5.67. MLSS moved +14.99% today. Year to date, MLSS is +32.60%; over the trailing twelve months it is -62.00%. Its 52-week range spans $0.22 to $1.39. Analyst consensus is buy with an average price target of $1.00. Rallies surfaces MLSS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Milestone Scientific Cuts Q1 Operating Loss to $828K as Medical Sales Double: Milestone Scientific cut operating expenses by over 30% in Q1 2026, narrowing its operating loss to $828,000 on stable $2.16 million revenues and doubling medical segment sales year-over-year. The company raised $2.15 million in April and reaffirmed guidance for $9.8–$10.2 million full-year revenue, targeting cash-flow breakeven in early 2027.
| Metric | Value |
|---|---|
| Price | $0.39 |
| Market Cap | $28.62M |
| P/E Ratio | -5.67 |
| EPS | $-0.07 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.39 |
| 52-Week Low | $0.22 |
| Volume | 3.37K |
| Avg Volume | 0 |
| Revenue (TTM) | $8.97M |
| Net Income | $-5.72M |
| Gross Margin | 71.40% |
1 analysts cover MLSS: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $1.00.